According to our data and projections, the global refined grade fish oil market was valued at $3.74 billion in 2022 and is anticipated to reach $4.53 billion by 2029, reflecting a compound annual growth rate (CAGR) of approximately -0.39% during the period from 2023 to 2029.

At the regional level, the Chinese market has undergone significant changes in recent years, with a market size of $399 million in 2022, representing about 10.6% of the global market. By 2029, it is projected to reach $592 million, with an anticipated global share of around 3.24%. In terms of consumption, North America was the world's largest consumer market in 2022, holding a 34% market share, followed by Europe and China with 26.8% and 10.6%, respectively. China is expected to see the most rapid growth in the coming years, with an estimated compound annual growth rate (CAGR) of approximately 3.24% during 2023-2029.

In the post-pandemic era, public awareness of nutrition and health has reached unprecedented levels. The younger generation, particularly Generation Z, is emerging as a key demographic in health-related consumption, recognizing the importance of heart and brain health. Additionally, in 2023, China officially entered a moderately aging society, signaling the beginning of an era of longevity. As the population ages, the consumption structure is shifting towards products that support brain health and overall well-being. Omega-related products, particularly those containing EPA and DHA, are seeing a significant increase in demand as people prioritize these essential fatty acids for their potential health benefits.

Fish oil, one of our company's flagship products, has earned the trust of customers both domestically and internationally through our commitment to high-quality supply chain management and competitive pricing. Our fish oil is exported to various countries and regions, including Europe, North America, Australia, Japan, and South Korea.

LongYoung Health Company Ltd.

Company Email：admin@longyounghealth.com